Skip to main content
. Author manuscript; available in PMC: 2009 Jan 26.
Published in final edited form as: Nat Med. 2008 Mar 30;14(4):413–420. doi: 10.1038/nm1741

Table 2.

GRG effects on CD4+ recovery in those initiating HAARTat <350 CD4+ cells/mm3

Pre-HAART CD4
count (cells/mm3)a
GRG status
Low versus moderate-high GRG
CD4 difference (s.e.m.), P
Low versus moderate GRG
CD4 difference (s.e.m.), P
Low Moderate-high Moderate
<350 3.23 (0.21)b 0.83 (0.22) 0.80 (0.24) 2.40 (0.29), 5.8 × 10−13 2.43 (0.31), 2.9 × 10−12
<300 3.52 (0.21) 0.28 (0.26) 0.23 (0.28) 3.24 (0.33), 5.0 × 10−16 3.29 (0.35), 6.2 × 10−12
<250 3.47 (0.25) −0.26 (0.27) −0.33 (0.30) 3.73 (0.37), 1.9 × 10−15 3.80 (0.39), 1.5 × 10−14
<200 4.51 (0.24) −0.23 (0.33) −0.22 (0.33) 4.74 (0.41), 3.6 × 10−16 4.73 (0.41), 8.1 × 10−16
<150 4.60 (0.30) −0.16 (0.37) −0.16 (0.37) 4.76 (0.47), 1.1 × 10−11 4.76 (0.47), 1.1 × 10−11
<100 4.82 (0.34) −0.06 (0.41) −0.06 (0.41) 4.88 (0.54), 1.5 × 10−9 4.88 (0.54), 1.5 × 10−9
<50 4.59 (0.52) −0.47 (0.90) −0.47 (0.90) 5.06 (1.04), 2.0 × 10−4 5.06 (1.04), 2.0 × 10−4

Data are for subjects from the WHMC HIV+ cohort who received HAART during chronic infection.

a

Pre-HAART CD4+ T cell count was the average of all CD4+ T cell counts during the 3 months before initiation of HAART.

b

Values are defined as in Table 1. Similar analyses were also conducted by using square-root-transformed CD4+ T cell counts (Supplementary Fig. 1f).